WALNUT CREEK, Calif., Aug. 21 /PRNewswire-FirstCall/ -- BriteSmile,
Inc. (NASDAQ:BSML), a leading provider of state-of-the-art
teeth-whitening systems, today released results for the second
quarter ended July 1, 2006. The results of BriteSmile's continuing
operations for the second quarter 2006 and all prior comparative
quarters presented in this report reflect the results of
BriteSmile's 17 whitening centers, retail product sales, supporting
overhead, and related assets and liabilities ("Centers Business").
The Centers Business was reclassified to continuing operations from
its treatment in the first quarter as a discontinued operation due
to the termination of the agreement to sell the Centers Business in
May. BriteSmile intends to continue operating its whitening
centers. Discontinued operations presented in this report for all
earlier comparative periods reflect the results of the Associated
Centers business that was sold to Discus Dental, Inc. in March
2006. Total revenue for the second quarter of 2006 was $7.8
million, up 52% compared to $5.1 million in the second quarter of
2005. The net loss in the second quarter of 2006 was $774,000 or
$(0.07) per share. This compares to a net loss of $6.8 million or
$(0.65) per share in the second quarter of 2005. EBITDA (earnings
before interest, tax, depreciation, and amortization) for the
second quarter ended July 1, 2006 was a negative $1.4 million,
compared to a negative EBITDA of $2.6 million in the second quarter
of 2005. Excluding approximately $2.2 million of post-close costs
related to the sale of the Associated Centers business and costs
related to the Company's legal claims, BriteSmile achieved an
adjusted positive EBITDA of approximately $800,000 on its
continuing Centers Business in the second quarter of 2006. EBITDA
is a non-GAAP financial measure. More information regarding this
non-GAAP financial measure, and a reconciliation of EBITDA to net
loss, the most directly comparable GAAP measure, is provided below.
"I am very pleased with the excellent performance of our whitening
centers in the second quarter," said John Reed, CEO of BriteSmile.
"Total whitening procedures performed in our 17 centers increased
by 84% in the second quarter of 2006 compared to a year ago. This
sales increase reflects a very strong response to our procedure
price reduction to $399 at the end of the first quarter, as well as
the addition of two spas since June of last year. At the same time,
we were able to significantly improve our advertising productivity
as we reduced advertising expense by approximately 60% compared to
the spend level in the second quarter of last year. We have also
streamlined the spa operating expenses which, combined with the
higher revenue levels, have improved the cash contribution of all
spas. Looking forward, BriteSmile will continue to drive the
Centers Business through advertising, promotions, and other retail
strategies to maximize the performance of BriteSmile," said Mr.
Reed. BriteSmile will not have an earnings conference call this
quarter. Please consult the Company's second quarter Form 10-Q
filed with the SEC for more information regarding second quarter
2006 results. BriteSmile markets the most advanced teeth whitening
technology available through 17 state-of-the-art BriteSmile
Professional Teeth Whitening Centers. BriteSmile Centers are
currently operating in Beverly Hills, Irvine, Palo Alto, Walnut
Creek, San Francisco and La Jolla, CA; Houston, TX; Denver, CO;
Boston, MA; McLean, VA; Atlanta, GA; New York, NY; Chicago and
Schaumburg, IL; and, Phoenix, AZ. For more information about
BriteSmile's procedure, call 1-800-BRITESMILE or visit the
Company's Website at http://www.britesmile.com/ . This release,
other than historical information, consists of forward- looking
statements that involve risks and uncertainties such as the
Company's ability to successfully and profitably operate the Spa
Center business. Readers are referred to the documents filed by
BriteSmile with the Securities and Exchange Commission,
specifically the Company's most recent reports on Forms 10-K and
10-Q, that identify important risk factors which could cause actual
results to differ from those contained in the forward-looking
statements. BriteSmile and its affiliates disclaim any intent or
obligation to update these forward-looking statements. Non-GAAP
Financial Information BriteSmile provides non-GAAP EBITDA or
earnings before interest, taxes, depreciation and amortization as
additional information for its operating results. These measures
are not in accordance with, or an alternative for financial
measures calculated in accordance with generally accepted
accounting principles, including net income or loss, the most
directly comparable GAAP measure, and may be different from
non-GAAP measures used by other companies. BriteSmile's management
believes this non-GAAP measure is useful to investors because of:
(i) the significant amount of non-cash depreciation and
amortization historically incurred by the Company in its operating
results ($1.2 million in first half 2005 and $0.8 million in first
half 2006), (ii) the non-cash amortization of the discount on debt
of $0.7 million in the second quarter of 2005, and (iii) the second
quarter results for 2006 included approximately $1.3 million of
gain from the settlement of the Procter and Gamble legal claim.
Investors are cautioned that the items excluded from EBITDA are
significant components in understanding and assessing BriteSmile's
financial performance. BRITESMILE, INC. CONDENSED CONSOLIDATED
BALANCE SHEETS ($ in thousands, except share data) July 1, 2006
Dec. 31, 2005 ASSETS (unaudited) CURRENT ASSETS: Cash and cash
equivalents $5,432 $5,518 Trade accounts receivable, net 709 113
Inventories 742 375 Assets held for sale - 12,214 Prepaid expenses
and other 503 1,159 Total Current Assets 7,386 19,379 Property and
equipment, net 5,007 5,847 Investments, restricted as to use 12,250
1,466 Other assets 924 1,150 TOTAL ASSETS $25,567 $27,842
LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Accounts
payable $1,449 $3,695 Accrued liabilities 10,904 7,533 Accrual for
Center closures 189 403 Gift certificate liability 1,245 1,235
Smile Forever - Deferred Revenue 1,306 1,197 Liabilities held for
sale - 803 Accrued interest due to a related party - 264 Long-term
debt with related party - current portion - 6,024 Convertible debt
- current portion - 6,828 Convertible debt with a related party --
current portion - 621 Financial instruments related to convertible
debt -- current portion - 9 Capital lease obligations with related
parties -- current portion - 73 Total Current Liabilities 15,093
28,685 LONG TERM LIABILITIES: Accrual for Center closures 344 242
Smile Forever Deferred Revenue 549 313 Other Long Term Liabilities
973 1,053 Total Long-term Liabilities 1,866 1,608 Total Liabilities
16,959 30,293 SHAREHOLDERS' EQUITY Common stock, $.001 par value 38
38 Preferred Stock, no par value - - Additional paid-in capital
173,491 173,340 Accumulated Deficit (164,921) (175,829) Total
shareholders' equity (deficit) 8,608 (2,451) TOTAL LIABILITIES AND
SHAREHOLDERS' EQUITY $25,567 $27,842 BriteSmile, Inc. Condensed
Consolidated Statements of Operations (Unaudited) (In Thousands
Except Share Data) 13 Weeks 13 Weeks 26 Weeks 26 Weeks Ended Ended
Ended Ended July 1, June 25, July 1, June 25, 2006 2005 2006 2005
REVENUES: Center whitening fees, net $6,430 $4,149 $10,943 $8,580
Product and other revenue (incl. Smile Forever) 1,330 953 2,852
1,826 Total revenues, net $7,760 $5,102 $13,795 $10,406 OPERATING
COSTS AND EXPENSES: Operating and occupancy costs 3,663 3,620 7,001
6,702 Selling, general and administrative expenses 5,477 3,975
9,374 7,926 Research and development expenses 45 74 90 341 Total
Operating Expense before depreciation & amortization 9,185
7,669 16,465 14,969 Operating Income/(Loss) before depreciation
& amortization $(1,425) $(2,567) $(2,670) $(4,563) (EBITDA)
Depreciation and amortization 714 591 821 1,161 Gain/(Loss) from
Continuing Operations (2,139) (3,159) (3,491) (5,723) OTHER
INCOME/(EXPENSES): Amortization of discount on debt - (663) (530)
(1,300) Loss on early extinguishment of debt - - (5,039) -
Gain/(Loss) on mark-to-market of convertible note instruments -
(99) - 2,631 Gain on settlement of legal claim 1,257 - 1,257 -
Other income/(expense), net 119 (517) (845) (725) Gain/(Loss) from
Continuing Operations before income tax (763) (4,438) (8,648)
(5,117) INCOME TAX 11 25 46 121 Net Income/(loss) from Continuing
Operations $(774) $(4,463) $(8,694) $(5,239) Gain/(Loss) from
Discontinued Operations, net of tax $- $(2,341) $19,602 $(4,753)
Net Income/(Loss) $(774) $(6,804) $10,908 $(9,992) BASIC/DILUTED
NET LOSS PER SHARE FOR CONTINUING OPERATIONS $(0.07) $(0.42)
$(0.82) $(0.50) BASIC/DILUTED NET INCOME/(LOSS) PER SHARE FOR
DISCONTINUED OPERATIONS $- $(0.23) $1.85 $(0.45) BASIC/DILUTED NET
INCOME/(LOSS) PER COMMON SHARE $(0.07) $(0.65) $1.03 $(0.95)
WEIGHTED AVERAGE SHARES -- BASIC 10,549,423 10,548,621 10,549,277
10,519,416 WEIGHTED AVERAGE SHARES -- DILUTED 10,549,423 10,548,621
10,558,949 10,519,416 Reconciliation of EBITDA to Net Income: 13
weeks 13 weeks 26 weeks 26 weeks ended ended ended ended July 1,
June 25, July 1, June 25, 2006 2005 2006 2005 Net Income/(loss)
from Continuing Operations $(774) $(4,463) $(8,694) $(5,239) Add
back: Loss on early extinguishment of debt $- $- 5,039 $- Add back:
(Other income)/ expense, net $(119) $517 $845 $725 Add back:
Amortization of debt discount $- $663 $530 $1,300 Add back: Income
tax expense $11 $25 $46 $121 Add back: Depreciation and
amortization $714 $591 $821 $1,161 Gain/loss on legal settlement
(1,257) - (1,257) - (Gain)/loss from mark-to-market of financial
instruments related to convertible debt $- $99 $- $(2,631) EBITDA
$(1,425) $(2,567) $(2,670) $(4,563) DATASOURCE: BriteSmile, Inc.
CONTACT: investors, Kenneth A. Czaja, CFO of BriteSmile, Inc.,
+1-925-979-2658 Web site: http://www.britesmile.com/
Copyright
Invesco BulletShares 202... (NASDAQ:BSML)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Invesco BulletShares 202... (NASDAQ:BSML)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025